ArticleClinical and experimental medicine2026
ViMDT: a clinical data visual analysis tool for multi-disciplinary treatment of lung cancer.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Multi-disciplinary treatment (MDT) has become a routine practice in clinical cancer diagnosis and treatment, playing an indispensable role in clinical decision-making. By integrating expertise from multiple disciplines, MDT provides patients with individualized diagnosis and treatment strategies. However, there is not yet a specialized clinical data visualization tool for MDT. This paper develops a novel clinical data analysis visualization tool for MDT, which analyzes in-depth and displays patient data comprehensively. Specifically, this tool designs a latent Dirichlet allocation (LDA)-based visualization model for clinical unstructured data, and Z-Score-3σ transformation and hierarchical strategies for clinical structural data. Moreover, we propose to predict personalized anti-tumor drug efficacy based on topic keywords. The results showed that, compared with users who did not use the tool, the time cost in MDT decision-making for users who used the tool was reduced by 26.17%. Furthermore, the proposed drug efficacy prediction method achieved an accuracy rate of 71.08% on a dataset of 958 patients with non-small cell cancer treated with anti-tumor drugs. The proposed tool is potentially helpful for doctors in MDT tasks by vividly visualizing the large-scale complex clinical data and improving the MDT efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.